SERMO adds feature to Drug Ratings platform: 5 insights

Written by Megan Wood | August 07, 2017 | Print  |

SERMO, a global physician social network, unveiled an addition to its Drug Ratings platform.

Here are five insights:


1. The new feature allows physicians to research prescription drugs by FDA-approved indications.


2. SERMO Drug Ratings already enabled physicians to share their prescription drugs' reviews and ratings with each other.


3. Physicians rate the drugs based on efficacy, safety, tolerability, accessibility and adherence.


4. The addition allows physicians to compare different classes of drugs for specific conditions.


5. SERMO Drug Ratings includes 350,000 ratings and 23,000 comments. The tool encompasses more than 3,000 rated drugs.


More articles on practice management:
7 key points on the future of AAOS from new CEO Thomas Arend Jr.
Why medical practices need to maintain a positive online image
Dr. Jerome Adams confirmed as surgeon general — 6 things to know


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months